Advisor Net Financial, Inc Nevro Corp Transaction History

Advisor Net Financial, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$59.95 - $92.06 $13,728 - $21,081	-229 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$81.07 - $121.29 $2,675 - $4,002	33 Added 16.84%	229 $19,000
Q3 2021 Oct 15, 2021	SELL	$101.99 - $166.36 $815 - $1,330	-8 Reduced 3.92%	196 $23,000
Q1 2021 Apr 14, 2021	BUY	$132.81 - $182.18 $10,093 - $13,845	76 Added 59.38%	204 $28,000
Q3 2019 Oct 23, 2019	BUY	$61.52 - $91.1 $4,183 - $6,194	68 Added 113.33%	128 $11,000
Q4 2017 Feb 27, 2018	BUY	$65.94 - $93.31 $3,956 - $5,598	60	60 $4,000

145

37.6M

622K

1.39M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $203M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.